Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc(Min/+) mice
/in Dendritic Cells, Hyperthermia, International Publications /von 2007-09-24 / Cancer Sci. 2007 Dec;98(12):1930-5Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial
/in Cervical Cancer, International Publications /von 2007-09-19 / Int. J. Radiat. Oncol. Biol. Phys. 2008 Mar;70(4):1176-82Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination
/in International Publications, Malignant Lymphoma /von 2007-09-15 / Cancer Res. 2007 Sep;67(18):8450-5Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes
/in International Publications, Malignant Melanoma /von 2007-09-10 / Clin. Immunol. 2007 Nov;125(2):184-93An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
/in Breast Cancer, International Publications /von 2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-22Comparison of dendritic cell-mediated immune responses among canine malignant cells
/in International Publications, Malignant Lymphoma /von 2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-30Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2007-09-01 / Cancer Res. 2007 Sep;67(17):8285-92Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
/in Hypernephroma, International Publications /von 2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
/in Hypernephroma, International Publications /von 2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution